AXYNC, created in 2003 (Netherlands), from 402 sister brands and 17477 competing brands. The AXYNC brand is owned by Merck & Co, a company listed in New York. AXYNC is part of the Drug Manufacturers activity sector.

AXYNC is a brand of Merck & Co (MRK) Share price

Share price and profitability of the share Merck & Co (AXYNC)

Buy Merck & Co share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 131.95

Portfolio valuation
Merck & Co (AXYNC) over 5 years* USD 219.39

Stock market history Merck & Co (AXYNC)